John Nosenzo

Insider Reports History

Entity
Individual
Location
C/O Bioventus Inc., 4721 Emperor Boulevard, Suite 400, Durham, NC
Signature
/s/ Megan Smeykal, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Nosenzo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bioventus Inc. Fmr. Chief Commercial Officer Class A Common Stock 87.1K $361K $4.14 Oct 3, 2022 Direct
TELA Bio, Inc. Director Common Stock 6.27K $35.4K $5.65 Jun 1, 2023 Direct
TELA Bio, Inc. Director Stock Option (Right to Buy) 5.36K Jun 1, 2023 Direct

Insider Reports Filed by John Nosenzo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TELA TELA Bio, Inc. Jun 1, 2023 2 $0 4 Jun 2, 2023 Director
TELA TELA Bio, Inc. Jun 1, 2022 2 $0 4 Jun 2, 2022 Director
BVS Bioventus Inc. Apr 1, 2022 3 -$1.25K 4 Apr 21, 2023 Fmr. Chief Commercial Officer
BVS Bioventus Inc. Apr 1, 2022 3 -$734K 4 Apr 5, 2022 Chief Commercial Officer
BVS Bioventus Inc. Feb 11, 2022 3 -$6.4K 4 Feb 15, 2022 Chief Commercial Officer
BVS Bioventus Inc. Feb 10, 2022 3 $312K 4 Feb 14, 2022 CHIEF COMMERCIAL OFFICER
TELA TELA Bio, Inc. Jun 2, 2021 1 $0 4 Jun 4, 2021 Director
TELA TELA Bio, Inc. Jun 2, 2021 0 $0 3 Jun 4, 2021 Director